NBSE - SEC Form 8-K filings

NeuBase Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Leadership Update

NeuBase Therapeutics Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

NeuBase Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

NeuBase Therapeutics Inc. filed SEC Form 8-K: Other Events

NeuBase Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

NeuBase Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Leadership Update

NeuBase Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

NeuBase Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

NeuBase Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Leadership Update

NeuBase Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

NeuBase Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Leadership Update

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form 8-K filed by NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 8-K filed by NeuBase Therapeutics, Inc.

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Other Events

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

NeuBase Therapeutics, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

SEC Form 8-K filed by NeuBase Therapeutics, Inc.